Skip to content
May 28, 2024

Equity.Guru

Investment information for the new generation

Search

August 30, 2021

XPhyto Therapeutics (XPHY.C), with its partner and acquisition target, 3a-diagnostics GmbH announced today that it has successfully registered its first biosensor test in oral inflammation with the German authorities….
Silver has printed a reversal pattern as Fedchair Powell provided no taper timeline at Jackson Hole. The markets were expecting some sort of concrete timeline on tapering and rate…
On a 5-hour flight last weekend I watched the entirety of the American documentary miniseries, “This is a Robbery: The World’s Biggest Art Heist”.   On March 18th, 1990,…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however,…
Medexus Pharmaceuticals (MDP.TO) is a rare disease pharmaceutical company with a portfolio of innovative and high value rare disease products positioning the company for growth in the next decade…
“Medicine is a science of uncertainty and an art of probability.” – William Osler I think it’s appropriate I start the article by saying that I get it, biotech…